Study a home-made hepatitis B vaccine’s safety and immune response
Part of Digestive system, Infections clinical trials.
This Phase 3 study tests how well an in-house hepatitis B vaccine works in people’s bodies and whether it’s safe. It may help confirm the vaccine’s effectiveness for people in Indonesia, including children and adults.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 10 and 50 years old
- A study doctor must confirm you don’t have any major ongoing illness
- You (or a parent/guardian) must understand the study and sign consent (or give assent)
- You must agree to follow the study schedule and instructions
- You should not be taking part in another clinical trial at the same time
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a combined vaccine for six diseases in infants 6-11 weeks old. It aims to check if the vaccine is safe and helps babies build protection against diphtheria, tetanus, whooping cough, hepatitis B, Hib, and polio.
This early-phase study tests whether a hepatitis B vaccine (with an added ingredient to boost the immune response) can safely help people with long-term hepatitis B who are already on antiviral therapy. It is mainly looking at safety and how the immune system responds.
This study looks at how your body's cells respond after getting a hepatitis B vaccine. It may help researchers understand how well the vaccine works.
This study is testing a new hepatitis B vaccine called SN2001 in healthy adults. It will check how safe the vaccine is, what dose works best, and how well it helps your body build protection against hepatitis B.
This study tests a new injection called IB-001 in two groups: healthy people and people with chronic hepatitis B. The goal is to see if it's safe and how the body handles it at different doses. It might offer a new treatment option for hepatitis B in the future.
This trial tests an experimental vaccine therapy to help control or possibly cure chronic hepatitis B. It is designed to see whether the treatment is safe and how well it affects the hepatitis B virus in adults.
Hear when a new Vaccine Reaction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.